Germline BRCA1/2 mutation carriers have a high incidence of breast cancer in their lifetime [1]; the lifetime probability is approximately 57–65% for those with BRCA1 mutations and 45–49% for those with BRCA2 mutations [2]. The gene discussed is BRCA1; the disease is breast carcinoma.